FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.6  |  FHIR Version n/a  User: [n/a]

900000000000489007: Concept inactivation indicator attribute value reference set (foundation metadata concept)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT model component module (core metadata concept)

Descriptions:

Id Description Lang Type Status Case? Module
900000000001066017 Concept inactivation indicator attribute value reference set en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT model component module (core metadata concept)
900000000001067014 Concept inactivation indicator reference set en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT model component module (core metadata concept)
900000000001068016 Concept inactivation indicator attribute value reference set (foundation metadata concept) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT model component module (core metadata concept)


140498 members. Search Members:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Concept inactivation indicator reference set Is a Attribute value type true Inferred relationship Some

Members valueId
180 minute serum GH level A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
180 minute serum cortisol level A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
180 minute serum cortisol level A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
18000 A component that fails to comply with the current editorial guidance.
18000000 A component that fails to comply with the current editorial guidance.
181.43 A component that fails to comply with the current editorial guidance.
183 A component that fails to comply with the current editorial guidance.
184 A component that fails to comply with the current editorial guidance.
185 A component that fails to comply with the current editorial guidance.
187 A component that fails to comply with the current editorial guidance.
187.5 A component that fails to comply with the current editorial guidance.
1875 A component that fails to comply with the current editorial guidance.
18750 A component that fails to comply with the current editorial guidance.
18800 A component that fails to comply with the current editorial guidance.
189 A component that fails to comply with the current editorial guidance.
19 A component that fails to comply with the current editorial guidance.
19.4 A component that fails to comply with the current editorial guidance.
190 A component that fails to comply with the current editorial guidance.
192 A component that fails to comply with the current editorial guidance.
195 A component that fails to comply with the current editorial guidance.
196 A component that fails to comply with the current editorial guidance.
1H-benzotriazol A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
1H-benzotriazol A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
partiel trisomi 1q-syndrom Ambiguous
1st HiB and DTP vaccine given A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
1st Japanese encephalitis vaccination A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
1st Japanese encephalitis vaccination A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
to A component that fails to comply with the current editorial guidance.
2 hour post-prandial blood glucose level A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
2 hour post-prandial blood glucose level A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
2-4 anfald per måned A component that fails to comply with the current editorial guidance.
2, 3 Diphosphoglycerate A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
2,2-dichloro-1,1-difluoroethylmethyl-ether Ambiguous
2,3-Diaminopropionatoxalyltransferase Erroneous component (foundation metadata concept)
2,4,5-trichloroacetophenol A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
2,5-diaminotoluensulfat A component that fails to comply with the current editorial guidance.
2,5-Diokovaleratdehydrogenase Erroneous component (foundation metadata concept)
2,6-Di-tert-butyl-p-cresol A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
2-(2-Hydroxy-5-methylphenyl)benzotriazole A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
2-(4-Chloro-2-methylphenoxy)propionic acid A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
2-Aminoadipate A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
2-Cyclohexyl-4, 6-dinitrophenol A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
2-Ethylhexyl-p-dimethylaminobenzoate A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
2-Methyl,3-hydroxybutyrate A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
2-Oxoglutarate A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
2-Oxoglutarate measurement A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
2-Phenylbenzimidazole-5-sulfonic acid A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
2-Thio,4-Carboxythiazolidine Ambiguous
måling af 2-thio,4-carboxythiazolidin Ambiguous
2-ethylhydracrylate A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
2-hydroxycyclohexanone 2-monooxygenase (substance) A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
2-methylbutyrylglycinuri A component that is no longer current, useful, appropriate or acceptable.
2-octyl-cyanoacrylat-vævslim A component that fails to comply with the current editorial guidance.
2-octyl-cyanoacrylate topical tissue adhesive prefilled applicator A component that fails to comply with the current editorial guidance.
2-tert-Butyl-4-methoxyphenol A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
2.08 A component that fails to comply with the current editorial guidance.
2.083 A component that fails to comply with the current editorial guidance.
2.1 A component that fails to comply with the current editorial guidance.
2.16 A component that fails to comply with the current editorial guidance.
2.17 A component that fails to comply with the current editorial guidance.
2.2 A component that fails to comply with the current editorial guidance.
2.21 A component that fails to comply with the current editorial guidance.
2.25 A component that fails to comply with the current editorial guidance.
2.3 A component that fails to comply with the current editorial guidance.
2.4 A component that fails to comply with the current editorial guidance.
2.42 A component that fails to comply with the current editorial guidance.
2.49 A component that fails to comply with the current editorial guidance.
2.5 A component that fails to comply with the current editorial guidance.
2.5 year exam. NOS Classification derived component
2.5 year exam. normal A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
2.5 year exam. not attended A component that fails to comply with the current editorial guidance.
2.5 year exam. not offered A component that fails to comply with the current editorial guidance.
2.5 year exam. not wanted A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
2.5 year exam.abn.- referred A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
2.5 year examination NOS Classification derived component
2.5 year examination abnormal - for observation A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
2.5 year examination abnormal - on treatment A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
2,5-årsundersøgelse - patient ikke fremmødt A component that fails to comply with the current editorial guidance.
2,5-årsundersøgelse ikke tilbudt A component that fails to comply with the current editorial guidance.
2.52 A component that fails to comply with the current editorial guidance.
2.5X FLEA AND TICK POWDER Moved elsewhere
2.6 A component that fails to comply with the current editorial guidance.
2.68 A component that fails to comply with the current editorial guidance.
2.7 A component that fails to comply with the current editorial guidance.
2.72 A component that fails to comply with the current editorial guidance.
2.73 A component that fails to comply with the current editorial guidance.
2.74 A component that fails to comply with the current editorial guidance.
2.75 A component that fails to comply with the current editorial guidance.
2.86 A component that fails to comply with the current editorial guidance.
2.9 A component that fails to comply with the current editorial guidance.
2/5 A component that fails to comply with the current editorial guidance.
20 A component that fails to comply with the current editorial guidance.
20% ACTIVE VETERINARIAN TYPE DISINFECTANT Moved elsewhere
20.2 A component that fails to comply with the current editorial guidance.
200 A component that fails to comply with the current editorial guidance.
2000 A component that fails to comply with the current editorial guidance.
20000 A component that fails to comply with the current editorial guidance.
200000 A component that fails to comply with the current editorial guidance.
2000000 A component that fails to comply with the current editorial guidance.
20000000 A component that fails to comply with the current editorial guidance.
203.6 A component that fails to comply with the current editorial guidance.

Start Previous Page 30 of 1405 Next End


Reference Sets

Reference set descriptor

Back to Start